Filing Details

Accession Number:
0001225208-16-043154
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-12-14 12:10:40
Reporting Period:
2016-12-12
Filing Date:
2016-12-14
Accepted Time:
2016-12-14 12:10:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
9892 Bard C R Inc BCR Surgical & Medical Instruments & Apparatus (3841) 221454160
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1204663 H John Weiland C/O C. R. Bard, Inc.
730 Central Avenue
Murray Hill NJ 07974
Vice Chairman, Pres. And Coo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-12-12 11,190 $97.69 72,780 No 4 M Direct
Common Stock Disposition 2016-12-12 350 $217.28 72,430 No 4 S Direct
Common Stock Disposition 2016-12-12 1,000 $218.82 71,430 No 4 S Direct
Common Stock Disposition 2016-12-12 2,422 $220.35 69,008 No 4 S Direct
Common Stock Disposition 2016-12-12 7,418 $219.67 61,590 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option (Right to Buy) Disposition 2016-12-12 11,190 $0.00 11,190 $97.69
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2022-12-12 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 5,942 Indirect 401(k) Plan
Footnotes
  1. Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan.
  2. Represents the weighted average sales price for price increments ranging from $217.05 to $217.81. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
  3. Represents the weighted average sales price for price increments ranging from $218.12 to $219.10. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
  4. Represents the weighted average sales price for price increments ranging from $220.17 to $220.77. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
  5. Represents the weighted average sales price for price increments ranging from $219.16 to $220.15. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
  6. Includes 78.095 shares acquired under the Company's 401(k) Plan from February 6, 2016 to November 4, 2016.
  7. Options granted under 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).
  8. Options fully vested and are currently exercisable.